GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Equity-to-Asset

Mankind Pharma (BOM:543904) Equity-to-Asset : 0.00 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Mankind Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0 Mil. Mankind Pharma's Total Assets for the quarter that ended in Dec. 2023 was ₹0 Mil.

The historical rank and industry rank for Mankind Pharma's Equity-to-Asset or its related term are showing as below:

BOM:543904' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.67   Med: 0.74   Max: 0.77
Current: 0.76

During the past 3 years, the highest Equity to Asset Ratio of Mankind Pharma was 0.77. The lowest was 0.67. And the median was 0.74.

BOM:543904's Equity-to-Asset is ranked better than
76.08% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BOM:543904: 0.76

Mankind Pharma Equity-to-Asset Historical Data

The historical data trend for Mankind Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Equity-to-Asset Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22
Equity-to-Asset
0.69 0.74 0.67

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.77 - 0.76 -

Competitive Comparison of Mankind Pharma's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mankind Pharma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's Equity-to-Asset falls into.



Mankind Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Mankind Pharma's Equity to Asset Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Equity to Asset (A: Mar. 2022 )=Total Stockholders Equity/Total Assets
=61552.29/91477.4
=0.67

Mankind Pharma's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mankind Pharma  (BOM:543904) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Mankind Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Mankind Pharma (BOM:543904) Business Description

Traded in Other Exchanges
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines